232 related articles for article (PubMed ID: 23986578)
1. Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.
Bottero V; Sadagopan S; Johnson KE; Dutta S; Veettil MV; Chandran B
J Virol; 2013 Nov; 87(21):11806-20. PubMed ID: 23986578
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.
Paudel N; Sadagopan S; Balasubramanian S; Chandran B
J Virol; 2012 Feb; 86(3):1589-607. PubMed ID: 22130534
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis.
Sadagopan S; Sharma-Walia N; Veettil MV; Bottero V; Levine R; Vart RJ; Chandran B
J Virol; 2009 Apr; 83(7):3342-64. PubMed ID: 19158252
[TBL] [Abstract][Full Text] [Related]
7. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
Zhang YJ; Patel D; Nan Y; Fan S
Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
[TBL] [Abstract][Full Text] [Related]
10. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
[TBL] [Abstract][Full Text] [Related]
12. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
13. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
14. Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Fukumoto H; Kanno T; Hasegawa H; Katano H
Front Microbiol; 2011; 2():175. PubMed ID: 21904536
[TBL] [Abstract][Full Text] [Related]
15. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
16. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
Watanabe T; Fujimuro M
Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
[TBL] [Abstract][Full Text] [Related]
17. A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin.
Kadota A; Moriguchi M; Watanabe T; Sekine Y; Nakamura S; Yasuno T; Ohe T; Mashino T; Fujimuro M
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014678
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL).
Dai L; Trillo-Tinoco J; Bai L; Kang B; Xu Z; Wen X; Del Valle L; Qin Z
PLoS One; 2014; 9(2):e90349. PubMed ID: 24587336
[TBL] [Abstract][Full Text] [Related]
19. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
Santag S; Jäger W; Karsten CB; Kati S; Pietrek M; Steinemann D; Sarek G; Ojala PM; Schulz TF
Oncogene; 2013 Aug; 32(32):3676-85. PubMed ID: 22964633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
